questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Exome
Exome : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Séquençage de l'ADN
Génétique médicale
Maladies génétiques
Diagnostic génétique
Mutations génétiques
Analyse génomique
Symptômes
5
Symptômes
Maladies génétiques
Asymptomatique
Mutations génétiques
Prédiction
Analyse génomique
Maladies génétiques
Symptômes
Évolution des symptômes
Maladies génétiques
Prévention
5
Dépistage génétique
Prévention
Conseil génétique
Prévention
Dépistage prénatal
Génétique
Traitements
5
Thérapie génique
Traitements médicaux
Médecine personnalisée
Traitements
Maladies génétiques
Traitements
Médecine personnalisée
Traitements médicaux
Essais cliniques
Thérapie génique
Complications
5
Complications
Maladies génétiques
Prévision
Mutations génétiques
Traitements
Complications
Complications
Maladies génétiques
Qualité de vie
Complications
Facteurs de risque
5
Facteurs de risque
Hérédité
Environnement
Mutations génétiques
Antécédents médicaux
Facteurs de risque
Tests génétiques
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Exome : Questions médicales les plus fréquentes",
"headline": "Exome : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Exome : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-27",
"dateModified": "2025-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Exome"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Génome",
"url": "https://questionsmedicales.fr/mesh/D016678",
"about": {
"@type": "MedicalCondition",
"name": "Génome",
"code": {
"@type": "MedicalCode",
"code": "D016678",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Exome",
"alternateName": "Exome",
"code": {
"@type": "MedicalCode",
"code": "D059472",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "William D Foulkes",
"url": "https://questionsmedicales.fr/author/William%20D%20Foulkes",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, McGill University, Montreal, QC, Canada."
}
},
{
"@type": "Person",
"name": "Elizabeth Wohler",
"url": "https://questionsmedicales.fr/author/Elizabeth%20Wohler",
"affiliation": {
"@type": "Organization",
"name": "McKusick-Nathans Department of Genetic Medicine, Baylor Hopkins Center for Mendelian Genomics, Baltimore, MD 21205, USA."
}
},
{
"@type": "Person",
"name": "Nara Sobreira",
"url": "https://questionsmedicales.fr/author/Nara%20Sobreira",
"affiliation": {
"@type": "Organization",
"name": "McKusick-Nathans Department of Genetic Medicine, Baylor Hopkins Center for Mendelian Genomics, Baltimore, MD 21205, USA."
}
},
{
"@type": "Person",
"name": "Mordechai Shohat",
"url": "https://questionsmedicales.fr/author/Mordechai%20Shohat",
"affiliation": {
"@type": "Organization",
"name": "The Genetic Institute of Maccabi Health Services, Rehovot, Israel."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Personality assessment with Temperament and Character Inventory in Parkinson's disease.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/36030666",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.08.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of an Inconsistent Responding Scale for the HEXACO Personality Inventory-Revised.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36859786",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10731911231157620"
}
},
{
"@type": "ScholarlyArticle",
"name": "Construction of item-level scales from the Personality Assessment Inventory to assess levels of personality functioning.",
"datePublished": "2023-05-25",
"url": "https://questionsmedicales.fr/article/37227863",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/per0000628"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of personality disorder in the ICD-11 diagnostic system: Polish validation of the Personality Inventory for ICD-11.",
"datePublished": "2022-12-31",
"url": "https://questionsmedicales.fr/article/37098193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12740/PP/OnlineFirst/138563"
}
},
{
"@type": "ScholarlyArticle",
"name": "Item response theory analysis of the University Personality Inventory in medical students.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37366154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/npr2.12362"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Exome",
"item": "https://questionsmedicales.fr/mesh/D059472"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Exome - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Exome",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Exome",
"description": "Comment l'exome est-il analysé ?\nQuels tests sont utilisés pour l'exome ?\nQuand faire un séquençage de l'exome ?\nQuels résultats peut-on attendre d'une analyse d'exome ?\nL'exome peut-il aider au diagnostic de cancers ?",
"url": "https://questionsmedicales.fr/mesh/D059472?mesh_terms=Personality+Inventory#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Exome",
"description": "Quels symptômes peuvent indiquer une mutation de l'exome ?\nLes symptômes sont-ils toujours présents avec des mutations ?\nPeut-on prédire des symptômes par l'analyse de l'exome ?\nLes symptômes sont-ils spécifiques à l'exome ?\nLes symptômes peuvent-ils évoluer avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D059472?mesh_terms=Personality+Inventory#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Exome",
"description": "Peut-on prévenir les maladies liées à l'exome ?\nLe conseil génétique est-il utile ?\nLes changements de mode de vie peuvent-ils aider ?\nLes vaccinations sont-elles pertinentes ?\nLe dépistage prénatal est-il possible ?",
"url": "https://questionsmedicales.fr/mesh/D059472?mesh_terms=Personality+Inventory#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Exome",
"description": "Quels traitements sont disponibles pour les mutations de l'exome ?\nL'exome influence-t-il le choix du traitement ?\nPeut-on guérir les maladies liées à l'exome ?\nLes traitements sont-ils adaptés à chaque patient ?\nY a-t-il des essais cliniques pour les mutations de l'exome ?",
"url": "https://questionsmedicales.fr/mesh/D059472?mesh_terms=Personality+Inventory#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Exome",
"description": "Quelles complications peuvent survenir avec des mutations de l'exome ?\nLes complications sont-elles prévisibles ?\nLes complications peuvent-elles être traitées ?\nY a-t-il des risques de complications à long terme ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D059472?mesh_terms=Personality+Inventory#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Exome",
"description": "Quels sont les facteurs de risque pour les mutations de l'exome ?\nL'environnement influence-t-il les mutations ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes tests génétiques peuvent-ils identifier les risques ?\nLes facteurs de risque sont-ils modifiables ?",
"url": "https://questionsmedicales.fr/mesh/D059472?mesh_terms=Personality+Inventory#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment l'exome est-il analysé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exome est séquencé par des techniques de séquençage de nouvelle génération."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'exome ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le séquençage de l'exome entier et le ciblage de gènes spécifiques."
}
},
{
"@type": "Question",
"name": "Quand faire un séquençage de l'exome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé en cas de maladies génétiques rares ou de diagnostics incertains."
}
},
{
"@type": "Question",
"name": "Quels résultats peut-on attendre d'une analyse d'exome ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut identifier des mutations pathogènes ou des variations génétiques significatives."
}
},
{
"@type": "Question",
"name": "L'exome peut-il aider au diagnostic de cancers ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut révéler des mutations spécifiques liées à certains types de cancers."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une mutation de l'exome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon la maladie, incluant troubles neurologiques ou métaboliques."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents avec des mutations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines mutations peuvent être asymptomatiques ou avoir des manifestations légères."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des symptômes par l'analyse de l'exome ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse peut aider à anticiper des symptômes en fonction des mutations identifiées."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils spécifiques à l'exome ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes dépendent de la maladie sous-jacente et ne sont pas spécifiques à l'exome."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils évoluer avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains symptômes peuvent s'aggraver ou apparaître avec l'âge ou d'autres facteurs."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées à l'exome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est limitée, mais le dépistage génétique peut aider à identifier les risques."
}
},
{
"@type": "Question",
"name": "Le conseil génétique est-il utile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il aide les familles à comprendre les risques et les options de dépistage."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains changements peuvent réduire les risques, mais dépendent de la maladie spécifique."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles pertinentes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas les maladies génétiques, mais protègent contre d'autres infections."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal est-il possible ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage prénatal peut identifier certaines mutations génétiques avant la naissance."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les mutations de l'exome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements varient, incluant thérapies géniques, médicaments ciblés ou soins symptomatiques."
}
},
{
"@type": "Question",
"name": "L'exome influence-t-il le choix du traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'analyse de l'exome peut guider le choix des traitements personnalisés."
}
},
{
"@type": "Question",
"name": "Peut-on guérir les maladies liées à l'exome ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies peuvent être traitées efficacement, mais beaucoup restent incurables."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils adaptés à chaque patient ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent personnalisés en fonction des résultats de l'exome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques pour les mutations de l'exome ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux essais cliniques explorent de nouveaux traitements pour ces mutations."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des mutations de l'exome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications varient, incluant des troubles neurologiques, métaboliques ou cancéreux."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées en fonction des mutations identifiées."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées avec des traitements appropriés, d'autres non."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations peuvent entraîner des complications chroniques ou progressives."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les mutations de l'exome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, l'âge parental avancé et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'environnement influence-t-il les mutations ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions environnementales peuvent augmenter le risque de mutations génétiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents médicaux familiaux de maladies génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils identifier les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests peuvent révéler des prédispositions génétiques à certaines maladies."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils modifiables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains facteurs, comme le mode de vie, peuvent être modifiés pour réduire les risques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, McGill University, Montreal, QC, Canada.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Department of Medical Genetics, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
McKusick-Nathans Department of Genetic Medicine, Baylor Hopkins Center for Mendelian Genomics, Baltimore, MD 21205, USA.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
McKusick-Nathans Department of Genetic Medicine, Baylor Hopkins Center for Mendelian Genomics, Baltimore, MD 21205, USA.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
The Genetic Institute of Maccabi Health Services, Rehovot, Israel.
School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Bioinformatics Unit, Cancer Research Center, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands. christian.gilissen@radboudumc.nl.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, P.R. China.
Department of Ophthalmology, Ineye Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610032, P.R. China.
Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610032, P.R. China.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, P.R. China.
Department of Ophthalmology, Ineye Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610032, P.R. China.
Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610032, P.R. China.
Department of Ophthalmology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100006, P.R. China.
Publications dans "Exome" :
2 publications dans cette catégorie
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Center for Precision Environmental Health, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Center for Precision Environmental Health, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Departments of Molecular and Human Genetics and Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
Faculty of Science, Department of Biochemistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Institute for Genomic Medicine, Columbia University Medical Center, New York, New York.
Division of Nephrology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian, New York, New York.
Publications dans "Exome" :
2 publications dans cette catégorie
Affiliations :
Institute for Genomic Medicine, Columbia University Medical Center, New York, New York.
Publications dans "Exome" :
There is a growing interest in personality evaluation in Parkinson's disease (PD), following observations of specific temperaments in PD patients. Therefore, our objective was to evaluate personality ...
Fluctuating PD patients from the PREDISTIM cohort were included. Description of TCI dimensions and comparison with a French normative cohort were performed. Pearson correlations between TCI dimensions...
The 570 PD patients presented significant higher scores in Harm Avoidance, Reward Dependence, Persistence, Self-Directedness and Cooperativeness and significant lower scores in Self-Transcendence comp...
The TCI seems to be an adequate tool to evaluate personality dimensions in PD with good structural and internal consistencies. These fluctuating PD patients also have specific personality dimensions c...
Inconsistent or careless responding is a significant threat to the validity of self-reported personality data. Using archival samples of undergraduate and community participants, we developed an incon...
The fifth edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM-5; American Psychiatric Association, 2013) introduced the clinician-rated Levels of Personality Functioning Scale (...
This paper presents results of a study on the Polish adaptation of the Personality Inventory for ICD-11 (PiCD), which was developed to measure pathological traits under a new, dimensional model of per...
The study involved a non-clinical sample of N = 597 adults (51.4% female; Mage = 30.24 years; SD = 12.07 years). For convergent and divergent validity, Personality Inventory for DSM-5 (PID-5) and Big ...
The results showed the Polish adaptation of the PiCD to be reliable and valid. Cronbach's alpha coefficient for PiCD scale scores ranged from 0.77 to 0.87 (Mα = 0.82). The four-factor structure of PiC...
Obtained data demonstrate satisfactory internal consistency, factorial validity, and convergent-discriminant validity of the Polish adaptation of PiCD in a non-clinical sample....
Young adulthood has been recognized as an important period for the transition from adolescence to adulthood. The University Personality Inventory (UPI), a mental health questionnaire for young adultho...
Japanese medical students (n = 1185) participated in this study, and the UPI was completed at the time of university admission. The two-parameter IRT model was used to assess the measurement character...
Among all participants, 35.4% (420/1185) had total UPI score of 21 or more, and 10.6% (126/1185) indicated that they had the idea of wanting to die (item 25). For further IRT analysis, unidimensionali...
The UPI is useful to assess mild or moderate mental health problems, while precision may decline among individuals experiencing both little and extremely high levels of stress. Our findings provide a ...
The International Classification of Diseases 11th Revision (ICD-11) personality disorder model comprises, among other elements, five maladaptive personality trait domains (negative affectivity, detach...
The current study contributed to the validation of the PiCD validation by exploring its stability and predictive links with psychological distress over 6 months in a sample of 206 German community adu...
The PiCD trait domain scales displayed strong differential (all r ≥ .80) and absolute stability (all |d| ≤ .09). Additionally, PiCD negative affectivity predicted depression, anxiety, and stress, and ...
In sum, this study demonstrated the stability of the PiCD trait domain scores, supporting their utility for capturing relatively stable traits as described in the ICD-11. Additionally, we provided the...
In order to assess the internal consistency, fit indexes, test-retest reliability, and validity of the Personality Inventory for the DSM-5 (PID-5) and its associations with age, gender, and education,...
We found that; (a) temporal consistency of the Hungarian PID-5 was confirmed by one-month test-retest reliability analysis, (b) validity of the PID-5 instrument is acceptable in the clinical and the n...
These findings support that the Hungarian PID-5 is a reliable and valid instrument for both clinical and non-clinical populations....
The Personality Inventory for...
The relationship between maladaptive personality traits and psychotic disorders in the early stages of disease has not been thoroughly investigated, even though it is essential for developing preventi...
The five domains and the 25 facets of the Personality Inventory for DSM-5 (PID-5) were compared between 102 patients with recent-onset psychosis (ROP) and 116 community subjects (C) with a general lin...
Patients with ROP, compared to C, exhibited higher scores in four out of the five domains with medium effect sizes (Cohen's f...
Maladaptive personality traits were prominent in persons with ROP. These findings suggest that personality traits might play a role in vulnerability to psychosis and highlight the importance of evalua...
The current manuscript presents the convergence of the Dimensional Assessment of Personality Pathology (DAPP-BQ), using its short form the DAPP-90, and the Five-Factor Personality Inventory for Intern...